catalog number :
MBS421439
products full name :
Goat anti-PCK1/PEPCKC (internal) Antibody
products short name :
PCK1/PEPCKC
products name syn :
Goat Anti-PCK1 / PEPCKC (internal region) Antibody; PCK1; phosphoenolpyruvate carboxykinase 1 (soluble); HGNC: 8724; MGC22652; PEPCK1; PEPCKC; PEP carboxykinase; cytosolic phosphoenolpyruvate carboxykinase 1; phosphoenolpyruvate carboxylase; phosphopyruvate carboxylase; PEPCK-C; PCK1 antibody; phosphoenolpyruvate carboxykinase 1 (soluble) antibody; HGNC: 8724 antibody; MGC22652 antibody; PEPCK1 antibody; PEPCKC antibody; PEP carboxykinase antibody; cytosolic phosphoenolpyruvate carboxykinase 1 antibody; phosphoenolpyruvate carboxylase antibody; phosphopyruvate carboxylase antibody; PEPCK-C antibody; PCK1 / PEPCKC (internal)
other names :
phosphoenolpyruvate carboxykinase, cytosolic; Phosphoenolpyruvate carboxykinase, cytosolic [GTP]; phosphoenolpyruvate carboxykinase, cytosolic [GTP]; phosphoenolpyruvate carboxykinase 1
products gene name :
PCK1
products gene name syn :
PEPCKC
other gene names :
PCK1; PCK1; PEPCK1; PEPCKC; PEPCK-C; PEPCK-C
uniprot entry name :
PCKGC_HUMAN
reactivity :
Tested: Human; Expected from sequence similarity: Human, Mouse, Rat, Dog, Pig, Cow
purity :
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
form :
Supplied at 0.5 mg/ml in Tris saline, 0. 02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
concentration :
100ug specific antibody in 200ul
storage stability :
Aliquot and store at -20 degree C. Minimize freezing and thawing.
tested application :
Peptide ELISA (EIA), Immunohistochemistry (IHC)
app notes :
Peptide ELISA: Antibody detection limit dilution 1: 8000. Immunohistochemistry: In paraffin embedded Human Cerebral Cortex shows staining of cytoplasm in pyramidal cells. Recommended concentration, 2-4ug/ml. Western Blot: Preliminary experiments gave bands at approx 70kDa, 45kDa and 28kDa in Human Adipose, Kidney and Liver lysates after 0.3 ug/ml antibody staining. Please note that currently we cannot find an explanation in the literature for the additional bands we observe given the calculated size of 69.2 kDa according to NP_002582.2. All three detected bands were successfully blocked by incubation with the immunizing peptide (and BLAST results with the immunizing peptide sequence did not identify any other proteins to explain the additional bands).
other info1 :
Immunogen: Peptide with sequence C-HVNWFRKDKEGK, from the internal region of the protein sequence according to NP_002582.3. Epitope: Internal region
ncbi acc num :
NP_002582.3
ncbi gb acc num :
NM_002591.3
ncbi mol weight :
34,156 Da
ncbi pathways :
AMPK Signaling Pathway (989139); AMPK Signaling Pathway (992181); Abacavir Metabolism Pathway (1270228); Abacavir Transport And Metabolism Pathway (1270226); Adipocytokine Signaling Pathway (83093); Adipocytokine Signaling Pathway (505); Adipogenesis Pathway (198832); Citrate Cycle (TCA Cycle) Pathway (82927); Citrate Cycle (TCA Cycle) Pathway (288); Developmental Biology Pathway (1270302)
ncbi summary :
This gene is a main control point for the regulation of gluconeogenesis. The cytosolic enzyme encoded by this gene, along with GTP, catalyzes the formation of phosphoenolpyruvate from oxaloacetate, with the release of carbon dioxide and GDP. The expression of this gene can be regulated by insulin, glucocorticoids, glucagon, cAMP, and diet. Defects in this gene are a cause of cytosolic phosphoenolpyruvate carboxykinase deficiency. A mitochondrial isozyme of the encoded protein also has been characterized. [provided by RefSeq, Jul 2008]
uniprot summary :
PCK1: Catalyzes the conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle. Defects in PCK1 are the cause of cytosolic phosphoenolpyruvate carboxykinase deficiency (C-PEPCKD). A metabolic disorder resulting from impaired gluconeogenesis. It is a rare disease with less than 10 cases reported in the literature. Clinical characteristics include hypotonia, hepatomegaly, failure to thrive, lactic acidosis and hypoglycemia. Autoposy reveals fatty infiltration of both the liver and kidneys. The disorder is transmitted as an autosomal recessive trait. Belongs to the phosphoenolpyruvate carboxykinase [GTP] family. Protein type: Carbohydrate Metabolism - citrate (TCA) cycle; Carbohydrate Metabolism - glycolysis and gluconeogenesis; EC 4.1.1.32; Carbohydrate Metabolism - pyruvate; Lyase; Kinase, other. Chromosomal Location of Human Ortholog: 20q13.31. Cellular Component: cytoplasm; cytosol. Molecular Function: carboxylic acid binding; GDP binding; GTP binding; magnesium ion binding; manganese ion binding; phosphoenolpyruvate carboxykinase (GTP) activity. Biological Process: cellular response to potassium ion starvation; gluconeogenesis; glucose homeostasis; glucose metabolic process; glycerol biosynthetic process from pyruvate; internal protein amino acid acetylation; oxaloacetate metabolic process; response to activity; response to insulin stimulus. Disease: Phosphoenolpyruvate Carboxykinase Deficiency, Cytosolic